Literature DB >> 22044156

Novel insights into V-ATPase functioning: distinct roles for its accessory subunits ATP6AP1/Ac45 and ATP6AP2/(pro) renin receptor.

Eric J R Jansen1, Gerard J M Martens.   

Abstract

The vacuolar (H+)-ATPase (V-ATPase) is a universal proton pump and its activity is required for a variety of cell-biological processes such as membrane trafficking, receptor-mediated endocytosis, lysosomal protein degradation, osteoclastic bone resorption and maintenance of acid-base homeostasis by renal intercalated cells. In neuronal and neuroendocrine cells, the V-ATPase is the major regulator of intragranular acidification which is indispensable for correct prohormone processing and neurotransmitter uptake. In these specialized cells, the V-ATPase is equipped with the accessory subunits ATP6AP1/Ac45 and ATP6AP2/(pro) renin receptor. Recent studies have shown that Ac45 interacts with the V0- sector of the V-ATPase complex, thereby regulating the intragranular pH and Ca2+-dependent exocytotic membrane fusion. Thus, Ac45 can be considered as a V-ATPase regulator in the neuroendocrine secretory pathway. ATP6AP2 has recently been found to be identical to the (pro) renin receptor and has a dual role: (i) in the renin-angiotensin system that also regulates V-ATPase activity; (ii) acting as an adapter by binding to both the V-ATPase and the Wnt receptor complex, thereby recruiting the receptor complex into an acidic microenvironment. We here provide an overview of the two V-ATPase accessory subunits as novel key players in V-ATPase regulation. We argue that the accessory subunits are candidate genes for V-ATPase-related human disorders and promising targets for manipulating V-ATPase functioning in vivo.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22044156     DOI: 10.2174/138920312800493160

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  17 in total

1.  A Novel GLP1 Receptor Interacting Protein ATP6ap2 Regulates Insulin Secretion in Pancreatic Beta Cells.

Authors:  Feihan F Dai; Alpana Bhattacharjee; Ying Liu; Battsetseg Batchuluun; Ming Zhang; Xinye Serena Wang; Xinyi Huang; Lemieux Luu; Dan Zhu; Herbert Gaisano; Michael B Wheeler
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

Review 2.  Regulation of lysosome biogenesis and functions in osteoclasts.

Authors:  Julie Lacombe; Gérard Karsenty; Mathieu Ferron
Journal:  Cell Cycle       Date:  2013-08-05       Impact factor: 4.534

3.  Identification of domains within the V-ATPase accessory subunit Ac45 involved in V-ATPase transport and Ca2+-dependent exocytosis.

Authors:  Eric J R Jansen; Nick H M van Bakel; Nikkie F M Olde Loohuis; Theo G M Hafmans; Tim Arentsen; Anthon J M Coenen; Wim J J M Scheenen; Gerard J M Martens
Journal:  J Biol Chem       Date:  2012-06-26       Impact factor: 5.157

4.  Hearing loss without overt metabolic acidosis in ATP6V1B1 deficient MRL mice, a new genetic model for non-syndromic deafness with enlarged vestibular aqueducts.

Authors:  Cong Tian; Leona H Gagnon; Chantal Longo-Guess; Ron Korstanje; Susan M Sheehan; Kevin K Ohlemiller; Angela D Schrader; Jaclynn M Lett; Kenneth R Johnson
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

5.  The V-ATPase accessory protein Atp6ap1b mediates dorsal forerunner cell proliferation and left-right asymmetry in zebrafish.

Authors:  Jason J Gokey; Agnik Dasgupta; Jeffrey D Amack
Journal:  Dev Biol       Date:  2015-08-05       Impact factor: 3.582

6.  ATP6AP1 deficiency causes an immunodeficiency with hepatopathy, cognitive impairment and abnormal protein glycosylation.

Authors:  Eric J R Jansen; Sharita Timal; Margret Ryan; Angel Ashikov; Monique van Scherpenzeel; Laurie A Graham; Hanna Mandel; Alexander Hoischen; Theodore C Iancu; Kimiyo Raymond; Gerry Steenbergen; Christian Gilissen; Karin Huijben; Nick H M van Bakel; Yusuke Maeda; Richard J Rodenburg; Maciej Adamowicz; Ellen Crushell; Hans Koenen; Darius Adams; Julia Vodopiutz; Susanne Greber-Platzer; Thomas Müller; Gregor Dueckers; Eva Morava; Jolanta Sykut-Cegielska; Gerard J M Martens; Ron A Wevers; Tim Niehues; Martijn A Huynen; Joris A Veltman; Tom H Stevens; Dirk J Lefeber
Journal:  Nat Commun       Date:  2016-05-27       Impact factor: 14.919

7.  Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.

Authors:  Jessica Okosun; Rachel L Wolfson; Jun Wang; Shamzah Araf; Lucy Wilkins; Brian M Castellano; Leire Escudero-Ibarz; Ahad Fahad Al Seraihi; Julia Richter; Stephan H Bernhart; Alejo Efeyan; Sameena Iqbal; Janet Matthews; Andrew Clear; José Afonso Guerra-Assunção; Csaba Bödör; Hilmar Quentmeier; Christopher Mansbridge; Peter Johnson; Andrew Davies; Jonathan C Strefford; Graham Packham; Sharon Barrans; Andrew Jack; Ming-Qing Du; Maria Calaminici; T Andrew Lister; Rebecca Auer; Silvia Montoto; John G Gribben; Reiner Siebert; Claude Chelala; Roberto Zoncu; David M Sabatini; Jude Fitzgibbon
Journal:  Nat Genet       Date:  2015-12-21       Impact factor: 38.330

Review 8.  The role of Ca2+ signaling in Parkinson's disease.

Authors:  Sofia V Zaichick; Kaitlyn M McGrath; Gabriela Caraveo
Journal:  Dis Model Mech       Date:  2017-05-01       Impact factor: 5.758

9.  The role of individual domains and the significance of shedding of ATP6AP2/(pro)renin receptor in vacuolar H(+)-ATPase biogenesis.

Authors:  Kenichiro Kinouchi; Atsuhiro Ichihara; Motoaki Sano; Ge-Hong Sun-Wada; Yoh Wada; Hiroki Ochi; Toru Fukuda; Kanako Bokuda; Hideaki Kurosawa; Naohiro Yoshida; Shu Takeda; Keiichi Fukuda; Hiroshi Itoh
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

10.  The (pro)renin receptor mediates constitutive PLZF-independent pro-proliferative effects which are inhibited by bafilomycin but not genistein.

Authors:  Sebastian Kirsch; Eva Schrezenmeier; Sabrina Klare; Daniela Zaade; Kerstin Seidel; Jennifer Schmitz; Sarah Bernhard; Dilyara Lauer; Mark Slack; Petra Goldin-Lang; Thomas Unger; Frank S Zollmann; Heiko Funke-Kaiser
Journal:  Int J Mol Med       Date:  2014-01-14       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.